Literature DB >> 19852013

Chivosazoles A and F, cytostatic macrolides from myxobacteria, interfere with actin.

Randi Diestel1, Herbert Irschik, Rolf Jansen, Mohammed W Khalil, Hans Reichenbach, Florenz Sasse.   

Abstract

Chivosazoles A and F, isolated from Sorangium cellulosum, showed high antiproliferative activity with different mammalian cell lines including human cancer cells. The chivosazoles caused a delay in G2/M phase of the cell cycle, and treated cells often contained two nuclei. By labeling F-actin it was shown that the actin cytoskeleton of the cells starts to break down after a few minutes of treatment. In vitro polymerization assays with purified G-actin revealed that the chivosazoles inhibit actin polymerization and also cause a depolymerization of pyrene-labeled F-actin microfilaments prepared in vitro. Chivosazoles are new tools for the investigation of issues concerning the actin cytoskeleton and they have a different mode of action from the known microfilament-disrupting compounds like rhizopodin and cytochalasin D.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19852013     DOI: 10.1002/cbic.200900562

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  3 in total

Review 1.  A comprehensive review of glycosylated bacterial natural products.

Authors:  Sherif I Elshahawi; Khaled A Shaaban; Madan K Kharel; Jon S Thorson
Journal:  Chem Soc Rev       Date:  2015-11-07       Impact factor: 54.564

Review 2.  Challenges and discoveries in the total synthesis of complex polyketide natural products.

Authors:  Ian Paterson; Nelson Yuen Sum Lam
Journal:  J Antibiot (Tokyo)       Date:  2017-10-25       Impact factor: 2.649

3.  An Expedient Total Synthesis of Chivosazole F: an Actin-Binding Antimitotic Macrolide from the Myxobacterium Sorangium Cellulosum.

Authors:  Simon Williams; Jialu Jin; S B Jennifer Kan; Mungyuen Li; Lisa J Gibson; Ian Paterson
Journal:  Angew Chem Int Ed Engl       Date:  2016-11-29       Impact factor: 15.336

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.